Current CDC surveillance data through mid-May 2026 show no active Level 4 Travel Health Notices, with all alerts limited to Level 3 or lower for outbreaks such as Ebola Bundibugyo virus in the Democratic Republic of the Congo and meningococcal disease. Official epidemiological monitoring indicates contained transmission for respiratory viruses, measles clusters, and vector-borne illnesses, none yet meeting the extreme-risk threshold of widespread threat with no available precautions required for a Level 4 designation. Recent internal CDC emergency activations, including a Level 3 response to a multi-country hantavirus cluster, reflect targeted monitoring rather than conditions justifying "Avoid All Travel" notices. Trader consensus at 75.5% for No reflects this baseline of manageable risks, though evolving case counts or new variants could shift assessments ahead of year-end surveillance updates.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেডCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,680 Vol.
$71,680 Vol.
Dec 31, 2026
$71,680 Vol.
$71,680 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC surveillance data through mid-May 2026 show no active Level 4 Travel Health Notices, with all alerts limited to Level 3 or lower for outbreaks such as Ebola Bundibugyo virus in the Democratic Republic of the Congo and meningococcal disease. Official epidemiological monitoring indicates contained transmission for respiratory viruses, measles clusters, and vector-borne illnesses, none yet meeting the extreme-risk threshold of widespread threat with no available precautions required for a Level 4 designation. Recent internal CDC emergency activations, including a Level 3 response to a multi-country hantavirus cluster, reflect targeted monitoring rather than conditions justifying "Avoid All Travel" notices. Trader consensus at 75.5% for No reflects this baseline of manageable risks, though evolving case counts or new variants could shift assessments ahead of year-end surveillance updates.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
মার্কেট ওপেন হয়েছে: Jan 19, 2026, 3:15 PM ET
ভলিউম
$71,680শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC surveillance data through mid-May 2026 show no active Level 4 Travel Health Notices, with all alerts limited to Level 3 or lower for outbreaks such as Ebola Bundibugyo virus in the Democratic Republic of the Congo and meningococcal disease. Official epidemiological monitoring indicates contained transmission for respiratory viruses, measles clusters, and vector-borne illnesses, none yet meeting the extreme-risk threshold of widespread threat with no available precautions required for a Level 4 designation. Recent internal CDC emergency activations, including a Level 3 response to a multi-country hantavirus cluster, reflect targeted monitoring rather than conditions justifying "Avoid All Travel" notices. Trader consensus at 75.5% for No reflects this baseline of manageable risks, though evolving case counts or new variants could shift assessments ahead of year-end surveillance updates.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ভলিউম
$71,680শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC surveillance data through mid-May 2026 show no active Level 4 Travel Health Notices, with all alerts limited to Level 3 or lower for outbreaks such as Ebola Bundibugyo virus in the Democratic Republic of the Congo and meningococcal disease. Official epidemiological monitoring indicates contained transmission for respiratory viruses, measles clusters, and vector-borne illnesses, none yet meeting the extreme-risk threshold of widespread threat with no available precautions required for a Level 4 designation. Recent internal CDC emergency activations, including a Level 3 response to a multi-country hantavirus cluster, reflect targeted monitoring rather than conditions justifying "Avoid All Travel" notices. Trader consensus at 75.5% for No reflects this baseline of manageable risks, though evolving case counts or new variants could shift assessments ahead of year-end surveillance updates.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেড
বাহ্যিক লিংক থেকে সাবধান।
বাহ্যিক লিংক থেকে সাবধান।
সচরাচর জিজ্ঞাসা